An ageing population is driving demand for advanced therapeutics. The global market for head and neck cancer therapeutics is ...
A Canadian Cancer Society report gives the first comprehensive look at the economic impact, including lost income and ...
TUESDAY, Nov. 26, 2024 (HealthDay News) -- Cisplatin is the go-to chemotherapy for people battling head-and-neck cancers, but ...
A new trial finds that cetuximab outperforms durvalumab as a second-line treatment in patients who cannot tolerate cisplatin.
A study found a common air pollutant in wildfire smoke, car exhaust, and industrial emissions increases the risk of certain ...
Opioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the ...
Highest association seen at five-year lag period, but significant associations also seen at no lag, up to 20-year lag period.
COMEDIAN Rhod Gilbert has opened up after being hit by a heartbreaking double tragedy just months after his battle with stage ...
PRESS RELEASE EnnoDC presents preliminary data for immunotherapy candidate CD40.HVac in HPV+ oropharyngeal cancer at ESMO IO 2024 Paris, France – EnnoDC, a clinical-stage biotech company pioneering ...
An Eastbourne man has raised thousands of pounds to help cancer patients after he carried out a sponsored 300 metre swim.
Treatment for more advanced and difficult-to-treat head and neck cancers can be improved with the addition of polyvinyl alcohol (PVA), the same ingredient used in children’s glue. Researchers found ...